Eagles Pharma Logo

Therapeutic Portfolios · South Sudan

Eagles Pharma Corporate Logo
Home Therapeutic Areas
Essential Formulary Focus

Targeted Therapeutic Categories for South Sudan

An informational overview of the essential pharmaceutical categories prioritized by Eagles Pharma to meet public health challenges in the Republic of South Sudan.

Pharmaceutical Manufacturing Facility
GMP Production Standards Alignment WHO-Prequalified Focus
Important Informational Notice & Regulatory Boundary: The therapeutic classes and molecules presented below are published strictly for corporate informational purposes, stakeholder alignment, and supply chain planning. Eagles Pharma is not an online pharmacy, does not sell medicines directly to individual consumers or patients, and does not provide clinical or prescribing advice. Every prospective pharmaceutical product is subject to regulatory clearance and registration with the Drug and Food Control Authority (DFCA) of the Republic of South Sudan prior to commercial distribution.
Antimalarial Therapies
Priority 01 · Endemic Disease

Antimalarial Therapies

Malaria remains the single leading contributor to hospital admissions and child mortality in South Sudan. Eagles Pharma prioritizes audited WHO-prequalified Artemisinin-based Combination Therapies (ACTs).

Storage Protocol: Zone IVb Controlled Ambient (≤30°C)
Target Facilities: Hospitals, PHCs, Community Dispensaries

Informational Category Description

South Sudan's hyper-endemic malaria transmission requires reliable year-round availability of both oral therapies for uncomplicated falciparum malaria and parenterals for severe pediatric and maternal malaria complications. Our planned procurement prioritizes multi-dose packaging suited for tropical humidity.

Uncomplicated Malaria Focus
• Artemether + Lumefantrine (Tablets & Dispersible)
• Artesunate + Amodiaquine
Severe & Emergency Protocols
• Injectable Artesunate (60mg, 120mg Vials)
• Artemether IM Injections
Subject to DFCA Dossier Approvals
Antibiotics & Anti-Infectives
Priority 02 · Stewardship Aligned

Antibiotics & Anti-Infectives

Essential antibacterial agents engineered to combat bacterial pneumonia, sepsis, diarrheal infections, and surgical site contamination while upholding antimicrobial stewardship.

WHO AWaRe Classification: Access & Watch Categories
Target Facilities: Hospitals, Surgical Centers, PHCs

Informational Category Description

Bacterial infections represent a frequent complication in vulnerable communities. Our proposed antibacterial portfolio is structured according to the WHO AWaRe framework to support proper clinical prescription practices and minimize the progression of antimicrobial resistance (AMR).

Access Category (First-Line)
• Amoxicillin + Clavulanic Acid (Oral & IV)
• Ampicillin & Cloxacillin formulations
• Doxycycline & Erythromycin
Watch Category (Hospital Inpatient)
• Ceftriaxone & Cefotaxime Injectable Vials
• Ciprofloxacin & Azithromycin
Subject to DFCA Dossier Approvals
Analgesics and Antipyretics
Priority 03 · Pain & Fever Management

Analgesics & Antipyretics

Vital pain relief and fever management medications essential across all outpatient consultations, postoperative recovery, trauma emergency care, and maternal health units.

Formulations: Oral Solid, Oral Liquid & IV Infusions
Target Facilities: Universal Care Coverage

Informational Category Description

Pain and high fever represent the most common presenting symptoms in South Sudanese healthcare clinics. Our proposed portfolio spans mild antipyretics suitable for pediatrics to moderate and severe analgesic therapies for surgical and trauma management.

Non-Opioid Antipyretics
• Paracetamol 500mg Tablets & 120mg/5ml Syrups
• Paracetamol 10mg/ml IV Infusions (Hospital use)
NSAIDs & Surgical Analgesia
• Ibuprofen 200mg / 400mg & Suspensions
• Diclofenac Sodium 50mg / 75mg Injectable
• Regulated hospital analgesics
Subject to DFCA Dossier Approvals
Understanding Non-Communicable Diseases
Priority 04 · Chronic Disease Care

Non-Communicable Diseases (NCDs)

Addressing South Sudan's escalating chronic disease burden with reliable maintenance therapies for hypertension, diabetes, and cardiovascular conditions.

Therapeutic Focus: Hypertension & Type 2 Diabetes
Key Challenge: Ensuring Uninterrupted Supply Cycles

Informational Category Description

While communicable illnesses dominate public health discussions, urban and semi-urban populations in South Sudan are experiencing significant rises in cardiovascular disease and diabetes. Treatment interruption in chronic conditions leads to severe strokes and renal failure; our focus is guaranteeing steady supply.

Cardiovascular & Hypertension
• Amlodipine 5mg & 10mg Tablets
• Enalapril 5mg & 10mg / Losartan 50mg
• Hydrochlorothiazide 25mg / Atenolol
Endocrine & Diabetes Care
• Metformin Hydrochloride 500mg & 850mg
• Glibenclamide & Glimepiride
• Baseline glucose monitoring consumables
Subject to DFCA Dossier Approvals
Other Healthcare Products & Consumables
Priority 05 · Hospital Essentials

Other Healthcare Products

Critical hospital consumables, intravenous replacement solutions, oral rehydration regimens, and maternal-child nutritional micronutrients.

Category Scope: Parenteral Fluids & Micronutrients
Logistics Requirement: High Bulk Volume Handling

Informational Category Description

Modern clinical care cannot function without steady access to sterile intravenous infusion fluids and oral rehydration therapies during cholera or gastrointestinal emergencies. Our planned portfolio bridges bulk hospital procurement with reliable logistics.

IV Solutions & Resuscitation
• Normal Saline (0.9% Sodium Chloride) 500ml
• Ringer’s Lactate Solution 500ml
• 5% & 10% Dextrose Infusion Bottles
Maternal & Child Health
• Low-Osmolarity Oral Rehydration Salts (ORS) + Zinc
• Iron + Folic Acid prenatal tablets
• Pediatric Vitamin A & Multivitamin drops
Subject to DFCA Dossier Approvals